Evonik (GB:0QDS)
LSE:0QDS
Holding GB:0QDS?
Track your performance easily

Evonik (0QDS) Technical Analysis

5 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
2Neutral
13Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Evonik’s (0QDS) Moving Averages Convergence Divergence (MACD) indicator is -0.30, suggesting Evonik is a Buy.
Evonik’s (0QDS) 20-Day exponential moving average is 20.22, while Evonik’s (0QDS) share price is €18.7, making it a Sell.
Evonik’s (0QDS) 50-Day exponential moving average is 20.22, while Evonik’s (0QDS) share price is €18.7, making it a Sell.

Evonik (0QDS) Pivot Points

Nov 08, 2024, 10:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.43
18.05
18.66
19.28
19.90
20.52
21.13
Fibonacci
18.05
18.52
18.81
19.28
19.75
20.04
20.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Evonik (0QDS) Moving Averages

Nov 08, 2024, 10:30 AM
Period
Simple
Exponential
MA5
19.69Sell
19.50Sell
MA10
20.03Sell
19.89Sell
MA20
20.47Sell
20.22Sell
MA50
20.43Sell
20.22Sell
MA100
19.69Sell
19.76Sell
MA200
18.61Buy
18.78Sell
Evonik’s (0QDS) 10-Day exponential moving average is 19.89, while Evonik’s (0QDS) share price is €18.7, making it a Sell.
Evonik’s (0QDS) 100-Day exponential moving average is 19.76, while Evonik’s (0QDS) share price is €18.7, making it a Sell.
Evonik’s (0QDS) stock price is €18.7 and Evonik’s (0QDS) 50-day simple moving average is 20.43, creating a Sell signal.
Evonik’s (0QDS) stock price is €18.7 and Evonik’s (0QDS) 100-day simple moving average is 19.69, creating a Sell signal.
Evonik’s (0QDS) stock price is €18.7 and Evonik’s (0QDS) 200-day simple moving average is 18.61, creating a Buy signal.

Evonik (0QDS) Technical Indicators

Nov 08, 2024, 10:30 AM
Name
Value
Implied Action
RSI (14)
18.25
Buy
STOCH (9,6)
19.57
Buy
STOCHRSI (14)
14.79
Buy
MACD (12,26)
-0.30
Buy
ADX (14)
32.86
Neutral
Williams %R
-92.34
Buy
CCI (14)
-260.60
Buy
ATR (14)
0.39
-
Ultimate Oscillator
41.91
Neutral
ROC
-11.58
Sell
Evonik’s (0QDS) Relative Strength Index (RSI) is 18.25, creating a Buy signal.
Evonik’s (0QDS) Trend Strength Indicator (ADX) is 32.86, creating a Neutral signal.
Evonik’s (0QDS) Commodity Channel Index (CCI) is -260.60, creating a Buy signal.
Evonik’s (0QDS) Price Rate of Change (ROC) is -11.58, creating a Sell signal.

FAQ

Is 0QDS a Buy, Hold, or Sell?
Based on 0QDS’s technical indicators, 0QDS is a Sell.
    What is 0QDS’s RSI (14)?
    0QDS’s RSI (14) is 18.25, which suggests 0QDS is a Buy.
      What is 0QDS’s MACD?
      0QDS’s MACD is -0.30, which suggests 0QDS is a Buy.
        What is 0QDS’s 5-day moving average?
        0QDS’s 5-day moving average is 19.69, which suggests 0QDS is a Sell.
          What is 0QDS’s 20-day moving average?
          0QDS 20-day moving average is 20.47, which suggests 0QDS is a Sell.
            What is 0QDS’s 50-day moving average?
            0QDS’s 50-day moving average is 20.43, which suggests 0QDS is a Sell.
              What is 0QDS’s 200-day moving average?
              0QDS’s 200-day moving average is 18.61, which suggests 0QDS is a Buy.
                What is 0QDS’s Williams % R (14)?
                0QDS’s Williams % R (14) is -92.34, which suggests 0QDS is a Buy.
                  What is 0QDS’s CCI (14)?
                  0QDS’s CCI (14) is -260.60, which suggests 0QDS is a Buy.
                    What is the share price of Evonik?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis